Industry Roundtable: Brains Behind Neurotech Discuss Innovation, Challenges Ahead (Part 2 of 3)
This article was originally published in The Pink Sheet Daily
Executive Summary
Neurotechnology Industry Organization Executive Director and four neuroscience CEOs discuss regulatory roadblocks and neurotech legislation during a roundtable discussion with "The Pink Sheet" DAILY.
You may also be interested in...
Industry Roundtable: Neurotech Execs Discuss Innovation, Challenges, Next Steps (part 4 of 4)
Can drug companies, government and academia solve the big problems together without cries of conflicted interest?
Industry Roundtable: Neurotech Execs Discuss Innovation, Challenges, Next Steps (part 4 of 4)
Can drug companies, government and academia solve the big problems together without cries of conflicted interest?
Industry Roundtable: Neurotech Execs Discuss Innovation, Challenges, Next Steps (part 2 of 4)
In part II of a series, panelists discuss venture capital, NIH grants, SBIR and foundation funding, as ways to support discovery.